Dyskinesias clinical trials at UC Davis

1 research study open to eligible people

SHINE Study: Testing a New Oral Drug to Treat Parkinson's Disease With Dyskinesia
“Volunteer for research and contribute to discoveries that may improve health care for you, your family, and your community!”
open to eligible people ages 18-85
This is a two-part, double-blind, placebo-controlled, randomized, multicenter Phase 2 clinical trial of JM-010 in patients with Parkinson's Disease.
Detroit, Michigan and other locations

Last updated: January 2023